ROSINI, MICHELA

ROSINI, MICHELA

Rete di Collaborazioni Statistiche Email Alert RSS Feed

Dettaglio

ROSINI, MICHELA 

DIPARTIMENTO DI FARMACIA E BIOTECNOLOGIE 

Docenti di ruolo di IIa fascia 

Pubblicazioni

Risultati 1 - 20 di 100 (tempo di esecuzione: 0.002 secondi).

TitoloAutore(i)AnnoPeriodicoEditoreTipoFile
1Alzheimer's disease: new approaches to drug discovery.Bolognesi M.L.; Matera R.; Minarini A.; Rosini M.; Melchiorre C.2009CURRENT OPINION IN CHEMICAL BIOLOGY1.01 Articolo in rivista-
2Benextramine and derivatives as novel human monoamine oxidases inhibitors: an integrated approachDi Paolo, Maria Luisa; Cozza, Giorgio; Milelli, Andrea; Zonta, Francesca; Sarno, Stefania; Minnit...i, Elirosa; Ursini, Fulvio; Rosini, Michela; Minarini, Anna2019THE FEBS JOURNAL1.01 Articolo in rivista-
3Benextramine derivatives as probes to target human monoamine oxidasesMaria Luisa Di Paolo; Andrea Milelli; Giorgio Cozza; Monica Rossetto; Michela Rosini; Anna Minarini2015AMINO ACIDS1.06 Abstract in rivista-
4Bis(7)-tacrine Derivatives as Multitarget-Directed Ligands: Focus on Anticholinesterase and Antiamyloid ActivitiesBolognesi ML; Bartolini M ; Mancini F ; Chiriano G ; Ceccarini L; Rosini M; Milelli A; Tumiatti V...; Andrisano V; Melchiorre C2010CHEMMEDCHEM1.01 Articolo in rivista-
5Bivalent tacrine-based acetylcholinesterase inhibitors: role of the spacer in the recognition process of the enzyme gorgeBolognesi M.L.; Bartolini M.; Cavalli A.; Rosini M.; Andrisano V.; Melchiorre C.2005s.l.4.02 Riassunto (Abstract)-
6Circular Dichroism: a Study of Reversible Binding HSA Binding of Lipocrine.A. De Simone; M. Pistolozzi; M. Rosini; C. Melchiorre; C. Bertucci20094.01 Contributo in Atti di convegno-
7Combining galantamine and memantine in dual-target new chemical entities for the treatment of Alzheimer’s diseaseSimoni E.; Daniele S.; Bottegoni G.; Pizzirani D.; Tarozzo G.; Reggiani A.; Trincavelli M.L.; Mar...tini C.; Piomelli D.; Melchiorre C.; Rosini M.; Cavalli A.20124.02 Riassunto (Abstract)-
8Combining galantamine and memantine in multitargeted, new chemical entities potentially useful in Alzheimer's disease.Simoni E.; Daniele S.; Bottegoni G.; Pizzirani D.; Trincavelli M.L.; Goldoni L.; Tarozzo G.; Regg...iani A.; Martini C.; Piomelli D.; Melchiorre C.; Rosini M.; Cavalli A.2012JOURNAL OF MEDICINAL CHEMISTRY1.01 Articolo in rivista-
9Controlled Iontophoretic Delivery in Vitro and in Vivo of ARN14140 - A Multitarget Compound for Alzheimer's DiseaseSinghal M.; Merino V.; Rosini M.; Cavalli A.; Kalia Y.N.2019MOLECULAR PHARMACEUTICS1.01 Articolo in rivista-
10Curcumin analogs as multi-target antioxidants: focus on mitochondria.E. Simoni; M. Rosini; C. Bergamini; R. Fato; M.L. Bolognesi; A. Cavalli; R. Motterlini; G. Lenaz;... C. Melchiorre2010s. n.4.02 Riassunto (Abstract)-
11Curcumin in Alzheimer's disease: Can we think to new strategies and perspectives for this molecule?Serafini, Melania Maria; Catanzaro, Michele; Rosini, Michela; Racchi, Marco; Lanni, Cristina2017PHARMACOLOGICAL RESEARCH1.01 Articolo in rivista-
12Cystamine-tacrine dimer: A new multi-target-directed ligand as potential therapeutic agent for Alzheimer's disease treatment.Minarini A.; Milelli A.; Tumiatti V.; Rosini M.; Simoni E.; Bolognesi M.L.; Andrisano V.; Bartoli...ni M.; Motori E.; Angeloni C.; Hrelia S.2012NEUROPHARMACOLOGY1.01 Articolo in rivista-
13Design, synthesis, and biological evaluation of conformationally restricted rivastigmine analoguesBolognesi M. L.; Bartolini M.; Cavalli A.; Andrisano V.; Rosini M.; Minarini A.; Melchiorre C.2004JOURNAL OF MEDICINAL CHEMISTRY1.01 Articolo in rivista-
14Design, synthesis, and biological evaluation of pirenzepine analogs bearing a 1,2-cyclohexanediamine and a perhydroquinoxaline units in exchange for the piperazine ring as antimuscarinicsA. Minarini; G. Marucci; C. Bellucci; G. Giorgi; V. Tumiatti; M. L. Bolognesi; R. Matera; M. Rosi...ni; C. Melchiorre2008BIOORGANIC & MEDICINAL CHEMISTRY1.01 Articolo in rivista-
15Design, synthesis, and biological evaluation of prazosin-related derivatives as multipotent compoundsA. Antonello; P. Hrelia; A. Leonardi; G. Marucci; M. Rosini; A. Tarozzi; V. Tumiatti; C. Melchiorre2005JOURNAL OF MEDICINAL CHEMISTRY1.01 Articolo in rivista-
16Design, synthesis, and biological evaluation of substituted 2,3-dihydro-1H-cyclopenta[b]quinolin-9-ylamine related compounds as fructose-1,6-bisphosphatase inhibitorsM. Rosini;
F. Mancini;
A. Tarozzi;
F. Colizzi;
V. Andrisano;
M.L. Bolognesi;
P. Hrelia;
C.... Melchiorre.		2006BIOORGANIC & MEDICINAL CHEMISTRY1.01 Articolo in rivista-
17Discovery of multipotent drugs for the teratment of Alzheimer's diseaseRosini M.; Andrisano V.; Bartolini M.; Bolognesi M.L.; Cavalli A.; Minarini A.; Recanatini M.; Tu...miatti V.; Melchiorre C.2005SCIENTIA PHARMACEUTICA4.02 Riassunto (Abstract)-
18Dual target compounds for the treatment of Alzheimer’s disease.Cavalli A.; Rosini M.; Simoni E.; Reggiani A.; Melchiorre C.20136.01 Brevetto-
19EVALUATION OF NOVEL POLYAMINE AND MEMANTINE-DERIVATIVE COMPOUNDS TARGETING NMDA RECEPTORS FOR ALZHEIMER'S DISEASE TREATMENTAbu, I.F.; Rosini, M.; Mellor, I.R.2015NEURODEGENERATIVE DISEASES1.06 Abstract in rivista-
20Exploiting RNA as a new biomolecular target for synthetic polyaminesMinarini A.; Milelli A.; Tumiatti V.; Rosini M.; Lenzi M.; Ferruzzi L.; Turrini E.; Hrelia P.; Se...stili P.; Calcabrini C.; Fimognari C.2013GENE1.01 Articolo in rivista-
 
 
 
Powered by IRIS-about IRIS-Utilizzo dei cookie
Logo CINECA  Copyright © 2021